{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T02:47:07Z","timestamp":1792637227493,"version":"4.5.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,20]],"date-time":"2025-08-20T00:00:00Z","timestamp":1755648000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,8,20]],"date-time":"2025-08-20T00:00:00Z","timestamp":1755648000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Patient Rep Outcomes"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Post-acute sequelae of COVID-19 (PASC) or Long COVID is a post-viral complication of SARS-CoV-2 infection, causing ongoing symptoms and impaired function over a prolonged period of time. There is limited understanding of how the signs and symptoms of Long COVID\/PASC affect patients\u2019 lives and how to measure them, which is essential when developing care strategies. This study aimed to develop and evaluate the content validity for a novel patient-reported outcome (PRO) instrument in Long COVID\/PASC through qualitative research, which was informed by the patient experience of Long COVID\/PASC and both patient and clinician input.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>A review of literature and PRO instruments developed for Long COVID\/PASC identified measurement gaps for the context of use (i.e., weekly assessment of signs\/symptoms in clinical trial research). This informed the development of the preliminary Long COVID\/PASC PRO instrument, which was tested via patient interviews (combined concept elicitation and cognitive debriefing) to align with regulatory standards, and discussions with clinical experts were conducted to provide clinical insights. The final instrument was modified based on this input to further promote its content validity.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Thirty participants were interviewed about their Long COVID\/PASC experiences. Participants most frequently reported experiencing tiredness after physical activity (<jats:italic>n<\/jats:italic>\u2009=\u200929\/30; 97%), general tiredness (<jats:italic>n<\/jats:italic>\u2009=\u200928\/30; 93%), shortness of breath (<jats:italic>n<\/jats:italic>\u2009=\u200925\/30; 83%), cough (<jats:italic>n<\/jats:italic>\u2009=\u200923\/30; 77%) and muscle\/body aches (<jats:italic>n<\/jats:italic>\u2009=\u200923\/30; 77%). All participants reported that Long COVID\/PASC had an impact on their health-related quality of life. Almost all (<jats:italic>n<\/jats:italic>\u2009=\u200927\/28; 96%) sign\/symptom concepts were reported in the first three sets of interviews suggesting conceptual saturation was achieved. Items, response options and the recall period of the preliminary Long COVID\/PASC PRO instrument were understood as intended (\u2265\u200990%) and relevant to most participants across both rounds (\u2265\u200947%). Modifications were made to the instrument following patient input, resulting in the 18-item Long COVID\/PASC instrument. Clinician input (<jats:italic>n<\/jats:italic>\u2009=\u20093) corroborated participant interview results, supporting the content validity of the Long COVID\/PASC PRO instrument.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>The Long COVID\/PASC PRO instrument has been developed in line with regulatory standards and the qualitative evidence demonstrated strong content validity in a Long COVID\/PASC population. Research to evaluate psychometric properties will provide further evidence of the instrument\u2019s measurement properties.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s41687-025-00942-w","type":"journal-article","created":{"date-parts":[[2025,8,20]],"date-time":"2025-08-20T09:59:48Z","timestamp":1755683988000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Development and content validation of the Long COVID\/ post-acute sequelae of COVID-19 (PASC) patient-reported outcome (PRO) instrument"],"prefix":"10.1186","volume":"9","author":[{"given":"Dale","family":"Chandler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Abramoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Candace","family":"Bramson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph. C.","family":"Cappelleri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aishwarya","family":"Chohan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magdalena","family":"Harrington","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiba","family":"Jamal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jillian","family":"Lusk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iyar","family":"Mazar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger","family":"Paredes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophi","family":"Tatlock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Ustianowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward","family":"Weinstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6278-4969","authenticated-orcid":false,"given":"Ruth","family":"Mokgokong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,20]]},"reference":[{"issue":"8","key":"942_CR1","doi-asserted-by":"publisher","first-page":"4350","DOI":"10.3390\/ijerph18084350","volume":"18","author":"A Sis\u00f3-Almirall","year":"2021","unstructured":"Sis\u00f3-Almirall A, Brito-Zer\u00f3n P, Conangla Ferrin L, Kostov B, Moragas Moreno A, Mestres J et al (2021) Long Covid-19: proposed primary care clinical guidelines for diagnosis and disease management. Int J Environ Res Public Health 18(8):4350","journal-title":"Int J Environ Res Public Health"},{"key":"942_CR2","unstructured":"National Institute for Health and Care Excellence When should I suspect a diagnosis of COVID-19? 2024 [Available from: https:\/\/cks.nice.org.uk\/topics\/coronavirus-covid-19\/diagnosis\/diagnosis\/]"},{"key":"942_CR3","unstructured":"Centers for Disease Control and Prevention Clinical Presentation: Clinical considerations for care of children and adults with confirmed COVID-19 2024 [Available from: https:\/\/www.cdc.gov\/covid\/hcp\/clinical-care\/covid19-presentation.html#cdc_generic_section_5-symptoms]"},{"key":"942_CR4","unstructured":"World Health Organization (2023) Clinical Management of COVID-19"},{"key":"942_CR5","unstructured":"World Health Organization (2021) A clinical case definition of post COVID-19 condition by a Delphi consensus"},{"key":"942_CR6","unstructured":"National Academies of Sciences E (2024) Medicine. A long COVID definition: a chronic, systemic disease state with profound consequences"},{"key":"942_CR7","unstructured":"National Institute for Health and Care Excellence (2024) COVID-19 rapid guideline: managing the long-term effects of COVID-19"},{"issue":"7","key":"942_CR8","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1016\/S2213-2600(22)00135-7","volume":"10","author":"D Munblit","year":"2022","unstructured":"Munblit D, O\u2019Hara ME, Akrami A, Perego E, Olliaro P, Needham DM (2022) Long COVID: aiming for a consensus. Lancet Respiratory Med 10(7):632\u2013634","journal-title":"Lancet Respiratory Med"},{"issue":"4","key":"942_CR9","doi-asserted-by":"publisher","first-page":"e102","DOI":"10.1016\/S1473-3099(21)00703-9","volume":"22","author":"JB Soriano","year":"2022","unstructured":"Soriano JB, Murthy S, Marshall JC, Relan P, Diaz JV (2022) A clinical case definition of post-COVID-19 condition by a Delphi consensus. Lancet Infect Dis 22(4):e102\u2013e7","journal-title":"Lancet Infect Dis"},{"key":"942_CR10","unstructured":"Centers for Disease Control and Prevention Evaluating and caring for patients with post-COVID conditions: interim guidance 2021 [Available from: https:\/\/wwwcdcgov\/coronavirus\/2019-ncov\/hcp\/clinical-care\/post-covidindexhtml]"},{"key":"942_CR11","doi-asserted-by":"crossref","unstructured":"Tsampasian V, Elghazaly H, Chattopadhyay R, Debski M, Naing TKP, Garg P et al (2023) Risk factors associated with Post\u2009\u2013\u2009COVID-19 condition: a systematic review and Meta-analysis. JAMA Intern Med 183(6):566\u2013580","DOI":"10.1001\/jamainternmed.2023.0750"},{"issue":"1","key":"942_CR12","doi-asserted-by":"publisher","first-page":"e001075","DOI":"10.1136\/bmjresp-2021-001075","volume":"8","author":"S Buttery","year":"2021","unstructured":"Buttery S, Philip KE, Williams P, Fallas A, West B, Cumella A et al (2021) Patient symptoms and experience following COVID-19: results from a UK-wide survey. BMJ Open Respiratory Res 8(1):e001075","journal-title":"BMJ Open Respiratory Res"},{"issue":"22","key":"942_CR13","doi-asserted-by":"publisher","first-page":"1934","DOI":"10.1001\/jama.2023.8823","volume":"329","author":"T Thaweethai","year":"2023","unstructured":"Thaweethai T, Jolley SE, Karlson EW, Levitan EB, Levy B, McComsey GA et al (2023) Development of a definition of postacute sequelae of SARS-CoV-2 infection. JAMA 329(22):1934\u20131946","journal-title":"JAMA"},{"issue":"4","key":"942_CR14","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1038\/s41591-021-01283-z","volume":"27","author":"A Nalbandian","year":"2021","unstructured":"Nalbandian A, Sehgal K, Gupta A, Madhavan MV, McGroder C, Stevens JS et al (2021) Post-acute COVID-19 syndrome. Nat Med 27(4):601\u2013615","journal-title":"Nat Med"},{"key":"942_CR15","unstructured":"Food and Drug Administration. Guidance for Industry: Patient-Reported Outcome Measures: Use in Medical Product Development to Support Labeling Claims (2009) [Available from: https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/patient-reported-outcome-measures-use-medical-product-development-support-labeling-claims]"},{"key":"942_CR16","unstructured":"Food and Drug Administration Patient-Focused Drug Development: Selecting, Developing, or Modifying Fit-for-Purpose Clinical Outcome Assessments 2022 [Available from: https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/patient-focused-drug-development-selecting-developing-or-modifying-fit-purpose-clinical-outcome]"},{"key":"942_CR17","unstructured":"European Medicines Agency European Network of Centres for Pharmacoepidemiology and Pharmacovigilance (ENCePP) Guide on Methodological Standards in Pharmacoepidemiology 2023 [Available from: http:\/\/www.encepp.eu\/standards_and_guidances\/methodologicalGuide.shtml]"},{"issue":"12","key":"942_CR18","doi-asserted-by":"publisher","first-page":"e084202","DOI":"10.1136\/bmjopen-2024-084202","volume":"14","author":"A-K Baalmann","year":"2024","unstructured":"Baalmann A-K, Blome C, Stoletzki N, Donhauser T, Apfelbacher C, Piontek K (2024) Patient-reported outcome measures for post-COVID-19 condition: a systematic review of instruments and measurement properties. BMJ Open 14(12):e084202","journal-title":"BMJ Open"},{"key":"942_CR19","unstructured":"Mokkink LB, Prinsen C, Patrick DL, Alonso J, Bouter LM, De Vet H et al (2019) COSMIN Study Design checklist for Patient-reported outcome measurement instruments. Amsterdam, The Netherlands. 2019:1\u201332"},{"issue":"2","key":"942_CR20","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1093\/cid\/ciab352","volume":"74","author":"VT Tran","year":"2022","unstructured":"Tran VT, Riveros C, Clepier B, Desvarieux M, Collet C, Yordanov Y et al (2022) Development and validation of the long coronavirus disease (COVID) symptom and impact tools: A set of Patient-Reported instruments constructed from patients\u2019 lived experience. Clin Infect Dis 74(2):278\u2013287","journal-title":"Clin Infect Dis"},{"key":"942_CR21","unstructured":"Food and Drug Administration Guidance for Industry: Patient-Reported Outcome Measures: Use in Medical Product Development to Support Labeling Claims 2009 [Available from: http:\/\/www.fda.gov\/downloads\/Drugs\/Guidances\/UCM193282.pdf]"},{"key":"942_CR22","unstructured":"International Society for Pharmacoeconomics and Outcomes Research Good Practices for Outcomes Research issued by the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) 2023 [Available from: http:\/\/www.ispor.org\/workpaper\/practices_index.asp]"},{"key":"942_CR23","unstructured":"Food and Drug Administration Guidance for Industry: Good Pharmacovigilance Practices and Pharmacoepidemiologic Assessment 2005 [Available from: https:\/\/www.fda.gov\/downloads\/drugs\/guidancecomplianceregulatoryinformation\/guidances\/ucm071696.pdf ]"},{"issue":"10","key":"942_CR24","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1080\/08870440903194015","volume":"25","author":"JJ Francis","year":"2010","unstructured":"Francis JJ, Johnston M, Robertson C, Glidewell L, Entwistle V, Eccles MP et al (2010) What is an adequate sample size? Operationalising data saturation for theory-based interview studies. Psychol Health 25(10):1229\u20131245","journal-title":"Psychol Health"},{"issue":"1","key":"942_CR25","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1177\/1525822X05279903","volume":"18","author":"G Guest","year":"2006","unstructured":"Guest G, Bunce A, Johnson L (2006) How many interviews are enough? An experiment with data saturation and variability. Field Methods 18(1):59\u201382","journal-title":"Field Methods"},{"issue":"3","key":"942_CR26","doi-asserted-by":"publisher","first-page":"A33","DOI":"10.1016\/j.jval.2015.03.198","volume":"18","author":"R Lamoureux","year":"2015","unstructured":"Lamoureux R, Shields A, Stokes J, Yaworsky A, Galipeau N (2015) How many subjects are enough for symptom-focused concept elicitation studies? A retrospective analysis of saturation across twenty-six studies. Value Health 18(3):A33","journal-title":"Value Health"},{"key":"942_CR27","doi-asserted-by":"crossref","unstructured":"Graneheim UH, Lindgren B-M, Lundman B (2017) Methodological challenges in qualitative content analysis: A discussion paper. Nurse Educ Today 56:29\u201334","DOI":"10.1016\/j.nedt.2017.06.002"},{"key":"942_CR28","unstructured":"Centers for Disease Control and Prevention (CDC) Underlying Conditions and the Higher Risk for Severe COVID-19 2024 [Available from: https:\/\/www.cdc.gov\/covid\/hcp\/clinical-care\/underlying-conditions.html]"},{"issue":"4","key":"942_CR29","first-page":"1179","volume":"74","author":"SD Vernon","year":"2023","unstructured":"Vernon SD, Hartle M, Sullivan K, Bell J, Abbaszadeh S, Unutmaz D et al (2023) Post-exertional malaise among people with long COVID compared to myalgic encephalomyelitis\/chronic fatigue syndrome (ME\/CFS). Work 74(4):1179\u20131186","journal-title":"Work"},{"key":"942_CR30","unstructured":"International Headache Society (2017) The International Classification of Headache Disorders 3rd Edition (ICHD-3). https:\/\/ihs-headacheorg\/wp-content\/uploads\/2020\/05\/ICHD-3-Pocket-versionpdf"},{"issue":"1","key":"942_CR31","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s41687-018-0053-6","volume":"2","author":"S Safikhani","year":"2018","unstructured":"Safikhani S, Gries KS, Trudeau JJ, Reasner D, R\u00fcdell K, Coons SJ et al (2018) Response scale selection in adult pain measures: results from a literature review. J Patient-Reported Outcomes 2(1):40","journal-title":"J Patient-Reported Outcomes"},{"key":"942_CR32","unstructured":"Food and Drug Administration Voice of the Patient Report Long COVID 2024 [Available from: https:\/\/www.fda.gov\/media\/177092\/download#:~:text=Patients%20described%20gastrointestinal%20symptoms%20and,reflux%2C%20gastroparesis%2C%20and%20IBS.]"},{"issue":"9","key":"942_CR33","doi-asserted-by":"publisher","first-page":"4253","DOI":"10.1002\/jmv.27878","volume":"94","author":"M Sivan","year":"2022","unstructured":"Sivan M, Preston N, Parkin A, Makower S, Gee J, Ross D et al (2022) The modified COVID-19 Yorkshire rehabilitation scale (C19-YRSm) patient-reported outcome measure for long Covid or Post-COVID-19 syndrome. J Med Virol 94(9):4253\u20134264","journal-title":"J Med Virol"},{"key":"942_CR34","doi-asserted-by":"crossref","unstructured":"Hughes SE, Haroon S, Subramanian A, McMullan C, Aiyegbusi OL, Turner GM et al Development and validation of the symptom burden questionnaire\u2122 for long covid: A Rasch analysis. MedRxiv. 2022:2022.01.16.22269146.","DOI":"10.1101\/2022.01.16.22269146"},{"issue":"1","key":"942_CR35","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1186\/s41687-024-00737-5","volume":"8","author":"D Rofail","year":"2024","unstructured":"Rofail D, Somersan-Karakaya S, Mylonakis E, Choi JY, Przydzial K, Marquis S et al (2024) The symptoms evolution of long COVID\u201319 (SE-LC19): a new patient-reported content valid instrument. J Patient-Reported Outcomes 8(1):87","journal-title":"J Patient-Reported Outcomes"},{"issue":"10","key":"942_CR36","doi-asserted-by":"publisher","first-page":"e14357","DOI":"10.1111\/ijcp.14357","volume":"75","author":"AL Cabrera Martimbianco","year":"2021","unstructured":"Cabrera Martimbianco AL, Pacheco RL, Bagattini \u00c2M, Riera R (2021) Frequency, signs and symptoms, and criteria adopted for long COVID-19: A systematic review. Int J Clin Pract 75(10):e14357","journal-title":"Int J Clin Pract"},{"issue":"8","key":"942_CR37","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1016\/j.jval.2011.06.013","volume":"14","author":"DL Patrick","year":"2011","unstructured":"Patrick DL, Burke LB, Gwaltney CJ, Leidy NK, Martin ML, Molsen E et al (2011b) Content validity\u2013establishing and reporting the evidence in newly developed patient-reported outcomes (PRO) instruments for medical product evaluation: ISPOR PRO good research practices task force report: part 2\u2013assessing respondent Understanding. Value Health 14(8):978\u2013988","journal-title":"Value Health"}],"container-title":["Journal of Patient-Reported Outcomes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41687-025-00942-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s41687-025-00942-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41687-025-00942-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T04:18:09Z","timestamp":1757477889000},"score":1,"resource":{"primary":{"URL":"https:\/\/jpro.springeropen.com\/articles\/10.1186\/s41687-025-00942-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,20]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["942"],"URL":"https:\/\/doi.org\/10.1186\/s41687-025-00942-w","relation":{},"ISSN":["2509-8020"],"issn-type":[{"value":"2509-8020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,20]]},"assertion":[{"value":"13 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was performed in accordance with the Declaration of Helsinki 1964 and its later amendments and in line with guidelines related to Good Clinical Practice. Ethical approval and oversight were obtained from Western Copernicus Group Independent Review Board (WCG IRB tracking number: 20232556). All data resulting from the study were handled in accordance Health Insurance Portability and Accountability (HIPAA) legislation and the General Data Protection Regulation (GDPR) for the security and privacy of health data. Written informed consent was obtained from all participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All participants provided informed consent indicating their data will be used for medical research purposes and the study results may be published.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"DC, AC, and HJ are employees of Adelphi Values Ltd, who received consulting fees from Pfizer to perform this study. ST was an employee of Adelphi Values Ltd at the time of research and is now an employee of Merck Serono. CB, JC, MH, JL, IM, EW, and RM are employees of Pfizer who provided funding for this study. BA, RP and AU received consulting fees as expert clinicians who provided input on the study design and data interpretation.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"105"}}